Literature DB >> 9065769

Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species.

T Toida1, H Yoshida, H Toyoda, I Koshiishi, T Imanari, R E Hileman, J R Fromm, R J Linhardt.   

Abstract

This study presents a comparison of heparan sulphate chains isolated from various porcine and bovine tissues. 1H-NMR spectroscopy (500 MHz) was applied for structural and compositional studies on intact heparan sulphate chains. After enzymic digestion of heparan sulphate using heparin lyase I (EC 4.2.2.7) II and III (EC 4.2.2.8), the compositions of unsaturated disaccharides obtained were determined by analytical capillary electrophoresis. Correlations between the N-sulphated glucosamine residues and O-sulphation and between iduronic acid content and total sulphation were discovered using the data obtained by NMR and disaccharide analysis. Heparan sulphate chains could be classified into two groups based on the sulphation degree and the iduronic acid content. Heparan sulphate chains with a high degree of sulphation possessed also a significant number of iduronic acid residues and were isolated exclusively from porcine brain, liver and kidney medulla. The presence and amount of N-unsubstituted glucosamine residues (GlcNp) was established in all of the heparan sulphates examined. The structural context in which this residue occurs was demonstrated to be: high sulphation domain --> 4)-beta-D-GlcAp-(1 --> 4)-alpha-D-GlcNp-(1 --> 4)-beta-D-GlcAp-(1 --> low sulphation domain (where GlcNp is 2-amino-2-deoxyglucopyranose, and GlcAp is glucopyranosyluronic acid), based on the isolation and characterization of a novel, heparin lyase III-derived, GlcNp containing tetrasaccharide and hexasaccharide. The results presented suggest that structural differences may play a role in important biological events controlled by heparan sulphate in different tissues.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065769      PMCID: PMC1218218          DOI: 10.1042/bj3220499

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Isolation and identification of glycosaminoglycans associated with purified nuclei from rat liver.

Authors:  K Furukawa; H Terayama
Journal:  Biochim Biophys Acta       Date:  1977-09-29

2.  Inhibition of atherosclerosis in cholesterol-fed rabbits by a heparitin sulfate. Preliminary communication.

Authors:  B J Grossman; J A Cifonelli; A K Ozoa
Journal:  Atherosclerosis       Date:  1971 Jan-Feb       Impact factor: 5.162

3.  Anticoagulantly active heparin-like molecules from vascular tissue.

Authors:  J A Marcum; R D Rosenberg
Journal:  Biochemistry       Date:  1984-04-10       Impact factor: 3.162

4.  Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families of N-sulphated polysaccharides.

Authors:  J T Gallagher; A Walker
Journal:  Biochem J       Date:  1985-09-15       Impact factor: 3.857

5.  Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines.

Authors:  M Nakajima; T Irimura; D Di Ferrante; N Di Ferrante; G L Nicolson
Journal:  Science       Date:  1983-05-06       Impact factor: 47.728

6.  Characterization of heparan sulfate proteoglycans synthesized by rat ovarian granulosa cells in culture.

Authors:  M Yanagishita; V C Hascall
Journal:  J Biol Chem       Date:  1983-11-10       Impact factor: 5.157

7.  The heparitin sulfates (heparan sulfates).

Authors:  A Linker; P Hovingh
Journal:  Carbohydr Res       Date:  1973-07       Impact factor: 2.104

8.  Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody.

Authors:  J van den Born; K Gunnarsson; M A Bakker; L Kjellén; M Kusche-Gullberg; M Maccarana; J H Berden; U Lindahl
Journal:  J Biol Chem       Date:  1995-12-29       Impact factor: 5.157

9.  Structural characterization of the oligosaccharides formed by depolymerization of heparin with nitrous acid.

Authors:  M J Bienkowski; H E Conrad
Journal:  J Biol Chem       Date:  1985-01-10       Impact factor: 5.157

10.  Fractionation and structural features of two heparin families with high antithrombotic, antilipemic and anticoagulant activities.

Authors:  P Bianchini; B Osima; B Parma; H B Nader; C P Dietrich; B Casu; G Torri
Journal:  Arzneimittelforschung       Date:  1985
View more
  45 in total

1.  Insights into the role of 3-O-sulfotransferase in heparan sulfate biosynthesis.

Authors:  Maria Cecília Zorél Meneghetti; Tarsis Gesteira Ferreira; Alexandre Keiji Tashima; Suely F Chavante; Edwin Alexander Yates; Jian Liu; Helena Bonciani Nader; Marcelo A Lima
Journal:  Org Biomol Chem       Date:  2017-08-16       Impact factor: 3.876

2.  Genogroup II noroviruses efficiently bind to heparan sulfate proteoglycan associated with the cellular membrane.

Authors:  Masaru Tamura; Katsuro Natori; Masahiko Kobayashi; Tatsuo Miyamura; Naokazu Takeda
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

3.  A structural analysis of glycosaminoglycans from lethal and nonlethal breast cancer tissues: toward a novel class of theragnostics for personalized medicine in oncology?

Authors:  Amanda Weyers; Bo Yang; Dae Sung Yoon; Jong-Hwan Park; Fuming Zhang; Kyung Bok Lee; Robert J Linhardt
Journal:  OMICS       Date:  2012-03

4.  Preparation and characterization of heparin hexasaccharide library with N-unsubstituted glucosamine residues.

Authors:  Qun Tao Liang; Jia Yan Du; Qing Fu; Jiang Hui Lin; Zheng Wei
Journal:  Glycoconj J       Date:  2015-08-15       Impact factor: 2.916

5.  Dromedary glycosaminoglycans: molecular characterization of camel lung and liver heparan sulfate.

Authors:  Mohammad Warda; Robert J Linhardt
Journal:  Comp Biochem Physiol B Biochem Mol Biol       Date:  2005-11-17       Impact factor: 2.231

6.  The iron-regulated surface determinant B (IsdB) protein from Staphylococcus aureus acts as a receptor for the host protein vitronectin.

Authors:  Giampiero Pietrocola; Angelica Pellegrini; Mariangela J Alfeo; Loredana Marchese; Timothy J Foster; Pietro Speziale
Journal:  J Biol Chem       Date:  2020-06-04       Impact factor: 5.157

7.  Evolutionary differences in glycosaminoglycan fine structure detected by quantitative glycan reductive isotope labeling.

Authors:  Roger Lawrence; Sara K Olson; Robert E Steele; Lianchun Wang; Rahul Warrior; Richard D Cummings; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

8.  Perlecan domain I-conjugated, hyaluronic acid-based hydrogel particles for enhanced chondrogenic differentiation via BMP-2 release.

Authors:  Amit K Jha; Weidong Yang; Catherine B Kirn-Safran; Mary C Farach-Carson; Xinqiao Jia
Journal:  Biomaterials       Date:  2009-09-23       Impact factor: 12.479

9.  Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes.

Authors:  Cathelijn J F Waaijer; Carlos E de Andrea; Andrew Hamilton; Jolieke G van Oosterwijk; Sally E Stringer; Judith V M G Bovée
Journal:  Virchows Arch       Date:  2012-08-18       Impact factor: 4.064

10.  Heparan sulfate phage display antibodies identify distinct epitopes with complex binding characteristics: insights into protein binding specificities.

Authors:  Sophie M Thompson; David G Fernig; Edwin C Jesudason; Paul D Losty; Els M A van de Westerlo; Toin H van Kuppevelt; Jeremy E Turnbull
Journal:  J Biol Chem       Date:  2009-12-18       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.